MANTI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.804
AS - Asia 1.551
EU - Europa 1.363
SA - Sud America 236
AF - Africa 203
OC - Oceania 3
Totale 5.160
Nazione #
US - Stati Uniti d'America 1.748
RU - Federazione Russa 693
SG - Singapore 633
CN - Cina 415
IT - Italia 299
BR - Brasile 192
VN - Vietnam 154
KR - Corea 145
CI - Costa d'Avorio 93
FR - Francia 71
IE - Irlanda 67
GB - Regno Unito 49
NG - Nigeria 48
HK - Hong Kong 42
IN - India 40
NL - Olanda 39
DE - Germania 36
FI - Finlandia 31
CA - Canada 29
AR - Argentina 20
BD - Bangladesh 20
IQ - Iraq 19
MX - Messico 19
PL - Polonia 19
ES - Italia 17
ZA - Sudafrica 17
BJ - Benin 15
JP - Giappone 13
ID - Indonesia 12
EC - Ecuador 10
SE - Svezia 10
PK - Pakistan 8
SN - Senegal 8
TR - Turchia 8
UA - Ucraina 6
AZ - Azerbaigian 5
CO - Colombia 5
CZ - Repubblica Ceca 5
MA - Marocco 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
PH - Filippine 4
AU - Australia 3
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
RS - Serbia 3
AL - Albania 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RE - Reunion 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
GA - Gabon 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
MW - Malawi 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
VA - Santa Sede (Città del Vaticano) 1
VE - Venezuela 1
Totale 5.160
Città #
Dallas 423
Singapore 397
Moscow 357
Santa Clara 227
Hefei 206
San Jose 149
Seoul 144
Ashburn 143
Los Angeles 129
Abidjan 93
Dublin 67
Beijing 60
Ho Chi Minh City 59
Chandler 58
Lauterbourg 52
Chicago 47
New York 47
Council Bluffs 40
Hong Kong 38
Buffalo 34
Catania 32
Hanoi 31
Abuja 30
São Paulo 30
Boardman 27
Lappeenranta 22
Civitanova Marche 20
Orem 19
Amsterdam 18
Lagos 18
Denver 17
London 17
Rome 17
Warsaw 17
Cotonou 15
Milan 15
Cambridge 14
Chennai 14
Lawrence 14
Bremen 13
Brooklyn 13
Poplar 13
Tokyo 13
Atlanta 11
Houston 10
Montreal 10
Rio de Janeiro 10
Stockholm 10
Johannesburg 9
Bắc Ninh 8
Dakar 8
Frankfurt am Main 8
Haiphong 8
Paris 8
Phoenix 8
Bologna 7
Mexico City 7
Baghdad 6
Bernareggio 6
Biancavilla 6
Da Nang 6
Dhaka 6
Genoa 6
Manchester 6
Naples 6
Querétaro 6
Ankara 5
Boston 5
Charlotte 5
Palermo 5
Redondo Beach 5
San Francisco 5
Seattle 5
Tashkent 5
Turku 5
Cesa 4
Dong Ket 4
Helsinki 4
Manaus 4
Mumbai 4
Munich 4
New Delhi 4
Reggio Emilia 4
Toronto 4
Turin 4
Verona 4
Baku 3
Bari 3
Belo Horizonte 3
Brasília 3
Brescia 3
Buenos Aires 3
Cagliari 3
Calgary 3
Casablanca 3
Curitiba 3
Des Moines 3
Erbil 3
Giarre 3
Kyiv 3
Totale 3.516
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 169
Headache and Diplopia after Rapid Maxillary Expansion: A Clue to Underdiagnosed Pseudotumor Cerebri Syndrome? 152
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 127
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 125
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 123
Lactoferrin: Cytokine modulation and application in clinical practice 121
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 120
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 119
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 116
Minor pulmonary malformations in a child 116
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 111
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 108
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 108
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 108
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 107
Protracted bacterial bronchitis: more to know 106
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 101
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 99
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 96
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 94
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 94
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 93
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 92
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 92
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 92
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 89
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 86
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 84
Food Allergies: Current and Future Treatments 83
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 82
An overview on viral interference during SARS-CoV-2 pandemic 82
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 82
UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants 82
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 82
Editorial: An overview on allergic and pulmonary diseases: from birth to childhood 80
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 78
Biologic drugs in chronic spontaneous urticaria 78
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 77
Impact of COVID-19 on the management of patients with Lysosomal Storage Disorders 73
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management 73
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 72
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 72
The role of skin infections in atopic dermatitis in children 69
Nasal microbiome in chronic rhinosinusitis 68
Type 2 inflammation in cystic fibrosis: New insights 64
HMGB1 as a Biomarker of Inhaled Corticosteroid Treatment Response in Moderate-Severe Asthmatic Children: A Single Center Pilot Study 61
Editorial: Nutrition, diet and allergic diseases 59
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 59
Management of asthma exacerbations in the paediatric population: A systematic review 59
Effects of Vertical Transmission of Respiratory Viruses to the Offspring 56
Paediatric Respiratory Diseases: From Clinical Experience to Literature Review 55
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 55
Correlation between RINT values and echocardiographic indices in pre-school children with chronic cough and wheezing 49
Observational study of sleep-related breathing disorders and preventive non-invasive ventilation in cystic fibrosis 48
Pidotimod in allergic diseases 48
Oral immunotherapy in children with allergic diseases: past, present and future 46
COVID-19 ocular manifestation in children 46
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 45
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab 44
An overview of HMGB1 and its potential role as a biomarker for RSV infection 41
Effectiveness of omalizumab in two children with severe vernal keratoconjunctivitis 40
Efficacy and Safety of Pidotimod in Childhood Wheezing: A Pilot Study 31
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics 27
Lung Clearance Index: A New Measure of Ventilation Inhomogeneity in Childhood Respiratory Diseases 18
Totale 5.232
Categoria #
all - tutte 15.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202252 0 6 0 0 2 0 2 0 14 2 2 24
2022/2023245 14 4 13 19 16 44 10 35 60 2 8 20
2023/2024179 5 26 12 11 5 44 1 9 3 6 35 22
2024/2025968 16 88 27 37 110 224 54 28 59 87 114 124
2025/20263.769 220 478 448 301 584 844 334 111 232 217 0 0
Totale 5.232